Tolka AI Therapeutics: Fighting antibiotic-resistant superbugs with personalized treatments š§¬

In this pitch, the presenter explains Tolka AI Therapeutics' approach to combating antibioticāresistant "superbug" infections using precision medicine powered by artificial intelligence. The core problem is that superbugs are a growing global health threat, and existing antibiotics are ineffective. Bacteriophages (phages) offer a solution because they can target specific bacterial strains without harming the human microbiome or host cells. However, their extreme specificity means a unique phage cocktail must be created for each patient. Tolka addresses this by integrating three recent technological advances: inexpensive genetic sequencing to rapidly identify the infecting bacteria, lab automation to replace laborāintensive phage isolation and testing, and machineālearning models to automate the decisionāmaking process for selecting effective phages. This combined AIāenabled pipeline aims to produce personalized phage therapies at scale, making precision antimicrobial treatment feasible. The presenter also notes that the Q&A with judges felt like a constructive dialogue.










